Finding the right fit: Effective thrombosis risk stratification in orthopedic patients

Orthopedics

Volumn 23, Issue 6 SUPPL., 2000, Pages

  Arcelus, Juan I ^a   Caprini, Joseph A ^b   Reyna, Jose J ^a  

^a Especialidad en Oftalmología Hospital Comarcal de la Axarquía Vélez Málaga Málaga   (Spain)

^b Evanston Northwestern Healthcare ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESULFATOHIRUDIN; LOW MOLECULAR WEIGHT HEPARIN;

ARTHROSCOPY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; RISK ASSESSMENT; RISK FACTOR; SURGICAL RISK; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS;

ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0033945030     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Prevention of venous thromboembolism. International consensus statement (guidelines according to scientific evidence). Int Angiol. 1997; 16:3-38.
2. Clagett GP, Anderson FA Jr, Geerts W, et al. Prevention of venous thromboembolism. Fifth ACCP Consensus Conference on Antithrombotic Therapy. Chest. 1998; 114(5 suppl):531S-560S.
3. Second Thromboembolic Risk Factors (THRiFT II) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. Phlebology. 1998; 13:87-97.
4. National Institutes of Health: Consensus Conference on prevention of venous thromboembolism and pulmonary embolism. JAMA. 1986; 256:744-748.
5. Arcelus JI, Candocia S, Traverso CI, et al. Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost. 1991; 17(suppl 3):313-318.
6. Caprini JA, Arcelus JI, Hasty JH, et al. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost. 1991; 17(suppl 3):304-312.
7. Lowe GDO, Osborne DM, McArdle BM, et al. Prediction and selective prophylaxis of venous thrombosis in elective gastro-intestinal surgery. Lancet. 1982; 1:409-412.
8. Haas S. Prophylaxie thromboembolique: Quand? Et pour combien de temps? Tribune Medicale. 1998; 16:4-5.
9. Chapuis Y. Prophylaxis des thromboses veineuses postoperatoires: Recommendations de l'Assistance Publique-Hospitaux de Paris. Sang Thrombose Vaisseaux. 1995; 7:119-120.
10. Clayton JK, Anderson JA, McNicol GP. Preoperative prediction of postoperative deep vein thrombosis. Br Med J. 1976; 11:910-912.
11. Sue-Ling HM, Johnston D, McMahon MJ, et al. Preoperative identification of patients at high risk of deep venous thrombosis after elective major abdominal surgery. Lancet. 1986; 1:1173-1176.
12. Wille-Jorgensen P, Borris L, Jorgensen LN, et al. Phlebography as the gold standard in thromboprophylactic studies? A multicenter interobserver variation study. Acta Radiol. 1992; 33:24-28.
13. Murray DW, Britton AR, Bulstrode CJK. Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg Br. 1996; 78:863-870.
14. Todd CJ, Freeman CJ, Camilleri-Ferrante C, et al. Differences in mortality after fracture of hip: The east Anglian audit. Br Med J. 1995; 310(6984):904-908.
15. Demers C, Marcoux S, Ginsberg JS. Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Arch Intern Med. 1998; 158:47-50.
16. Schippinger G, Wirnsberger GH, Obernosterer A, Babinski K. Thromboembolic complications after arthroscopic knee surgery. Acta Orthop Scand. 1998; 69:144-146.
17. Kock H-J, Schmit-Neuerburg KP, Hanke J, et al. Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg. Lancet. 1995; 346:459-461.
18. Kujath P, Spannagel U, Habscheid W, et al. Thrombosis prevention in outpatients with lower limb injuries. Dtsch Med Wschr. 1992; 117:6-10.
19. Mizel MS, Temple HT, Michelsen JD, et al. Thromboembolism after foot and ankle surgery. Clin Orthop. 1997; 348:180-185.
20. Anderson FA, Wheeler HB, Goldberg RJ, et al. Physician practices in the prevention of venous thromboembolism. Ann Intern Med. 1991; 115:591-595.
21. Storti S, Crucitti P, Cina G. Risk factors and prevention of venous thromboembolism. RAYS. 1996; 21:439-460.
22. McNally MA, Cooke EA, Harding ML, Mollan RAB. Attitudes to and utilization of low-molecular-weight heparins in joint replacement surgery. J Roy Coll Surg Edinb. 1997; 42:407-409.
23. Agnelli G, Sonaglia F. Prevention of venous thromboembolism in high risk patients. Haematologica. 1997; 82:496-502.
24. Anderson FA, Audet AM. Physician practices in the prevention of deep vein thrombosis: The MassPRO DVT Study. Orthopedics. 1996; 19(suppl):9-11.
25. Eriksson BI, Wille-Jorgensen P, Kalebo P, et al. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med. 1997; 337:1329-1335.